On July 22, CME Group Inc rose 3.53% in regular trading, trading at $250.025/share, with turnover of $45.95 million. The rally was driven by the company's second-quarter earnings report released pre-market, which exceeded market expectations on both revenue and profit.

CME Group reported adjusted earnings per share of $2.99, beating the consensus estimate of $2.91. Revenue came in at $1.706 billion, surpassing the expected $1.685 billion, while net income grew to approximately $1.042 billion. The strong performance was primarily fueled by heightened equity market volatility that drove increased hedging demand. Q2 derivatives average daily volume reached 29.8 million contracts, the second-highest level in the company's history, with June ADV surging 19% year-over-year to a monthly record.

Notably, multiple investment banks had cut their price targets ahead of the report, including JPMorgan to $249, Barclays to $270, and UBS to $260. The earnings beat effectively reversed prevailing bearish sentiment and triggered a significant intraday recovery.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)